Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 15;11(6):1091.
doi: 10.3390/diagnostics11061091.

Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19

Affiliations
Review

Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19

Ali A Rabaan et al. Diagnostics (Basel). .

Abstract

Real-time RT-PCR is considered the gold standard confirmatory test for coronavirus disease 2019 (COVID-19). However, many scientists disagree, and it is essential to understand that several factors and variables can cause a false-negative test. In this context, cycle threshold (Ct) values are being utilized to diagnose or predict SARS-CoV-2 infection. This practice has a significant clinical utility as Ct values can be correlated with the viral load. In addition, Ct values have a strong correlation with multiple haematological and biochemical markers. However, it is essential to consider that Ct values might be affected by pre-analytic, analytic, and post-analytical variables such as collection technique, specimen type, sampling time, viral kinetics, transport and storage conditions, nucleic acid extraction, viral RNA load, primer designing, real-time PCR efficiency, and Ct value determination method. Therefore, understanding the interpretation of Ct values and other influential factors could play a crucial role in interpreting viral load and disease severity. In several clinical studies consisting of small or large sample sizes, several discrepancies exist regarding a significant positive correlation between the Ct value and disease severity in COVID-19. In this context, a revised review of the literature has been conducted to fill the knowledge gaps regarding the correlations between Ct values and severity/fatality rates of patients with COVID-19. Various databases such as PubMed, Science Direct, Medline, Scopus, and Google Scholar were searched up to April 2021 by using keywords including "RT-PCR or viral load", "SARS-CoV-2 and RT-PCR", "Ct value and viral load", "Ct value or COVID-19". Research articles were extracted and selected independently by the authors and included in the present review based on their relevance to the study. The current narrative review explores the correlation of Ct values with mortality, disease progression, severity, and infectivity. We also discuss the factors that can affect these values, such as collection technique, type of swab, sampling method, etc.

Keywords: COVID-19; Ct values; RT-PCR; SARS-CoV-2; mortality; severity; viral load.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration of RT-PCR methodology and the detection of a positive sample in clinical practice, using a specific threshold and Ct value. The SARS-CoV-2 viral load is inversely proportional to the Ct values, and a lower Ct value corresponds to a high viral load, indicating a higher level of infectiousness. The figure was designed by Biorender.com program (https://biorender.com/, accessed on 15 April 2021).

References

    1. Wishaupt J.O., van der Ploeg T., Smeets L.C., de Groot R., Versteegh F.G.A., Hartwig N.G. Pitfalls in interpretation of CT-values of RT-PCR in children with acute respiratory tract infections. J. Clin. Virol. 2017;90:1–6. doi: 10.1016/j.jcv.2017.02.010. - DOI - PMC - PubMed
    1. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Dhama K., Patel S.K., Pathak M., Yatoo M.I., Tiwari R., Malik Y.S., Singh R., Sah R., Rabaan A.A., Bonilla-Aldana D.K., et al. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med. Infect. Dis. 2020;37 doi: 10.1016/j.tmaid.2020.101755. - DOI - PMC - PubMed
    1. Machhi J., Herskovitz J., Senan A.M., Dutta D., Nath B., Oleynikov M.D., Blomberg W.R., Meigs D.D., Hasan M., Patel M., et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J. Neuroimmune Pharmacol. 2020;15:359–386. doi: 10.1007/s11481-020-09944-5. - DOI - PMC - PubMed
    1. Attia Y.A., El-Saadony M.T., Swelum A.A., Qattan S.Y.A., Al-qurashi A.D., Asiry K.A., Shafi M.E., Elbestawy A.R., Gado A.R., Khafaga A.F., et al. COVID-19: Pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review. Environ. Sci. Pollut. Res. 2021;28:22241–22264. doi: 10.1007/s11356-021-13018-1. - DOI - PMC - PubMed

LinkOut - more resources